In the coming months, as many as 60 million doses of drugs are expected to be available for export
Washington— The White House told the Associated Press on Monday that once it passes the federal safety review, the United States will begin sharing all of its AstraZeneca coronavirus vaccines.
It is expected that as many as 60 million doses of medicine will be available for export in the coming months.
This move greatly expands the decision made by the Joe Biden administration last month to share approximately 4 million doses of vaccine with Mexico and Canada. AstraZeneca’s vaccine has been widely used worldwide, but has not yet been approved by the U.S. Food and Drug Administration (FDA).
Last weekend, the US regulator approved the resumption of the use of Johnson & Johnson’s single-dose injection.
Since the beginning of the pandemic, more than 3 million people worldwide have died of COVID-19.